Biotechnology

Winners Of The 2020 Breakthrough Prize In Life Sciences, Fundamental Physics And Mathematics Announced

SAN FRANCISCO, Sept. 5, 2019 /PRNewswire/ -- The Breakthrough Prize Foundation and its founding sponsors –Sergey Brin, Priscilla Chan and Mark Zuckerberg, Ma Huateng,Yuri and Julia Milner, and Anne Wojcicki – today announced the recipients of the 2020 Breakthrough Prize and 2020 New Horizons Priz...

2019-09-05 23:00 3649

Berkeley Lights Opens Shanghai Location

- Nobel Laureate, Professor James E. Rothman, PhD, to speak at all-day symposium onSeptember 5th - China Rep Office located in one of China's leading high-tech industry clusters SHANGHAI and EMERYVILLE, California, Sept. 5, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader ...

2019-09-05 08:06 2067

CROMSOURCE Continues US Growth With New Office in Research Triangle Park

CARY, North Carolina, Sept. 4, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office inCary, NC. Due to the growth of CROMSOURCE in the United States over the past few years, this new location serves as a complement to two ...

2019-09-04 21:00 1795

IDTechEx Research: The Future of Wearables is Medical

BOSTON, Sept. 4, 2019 /PRNewswire/ -- Wearable technology and medical devices have many prominent synergies. Electronic devices on the body are perfectly placed for sensors to collect data relevant to healthcare, with communication options allowing them to be the gateway to digital health data. C...

2019-09-04 10:00 4030

WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery

SHANGHAI and BOSTON, Sept. 3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing cost-effective and efficient hit finding services to expedite early drug discovery and bring new medicines to patients faster. DELigh...

2019-09-04 08:00 1841

Porsolt Increases Its Drug Discovery Service Capabilities With the Recent Expansion of Its Research Facility

LAVAL, France, Sept. 4, 2019 /PRNewswire/ -- Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 sq.ft. of experimental space.     The expansion integrates Porsolt's new areas of...

2019-09-04 00:03 2362

Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe

BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com ), a clinical stage biopharmaceutical company, announced today that it has successfully closed a Series A financing round totalingCHF 2.82 Million from private investors. These funds will enable ...

2019-09-03 14:00 3072

International Atherosclerosis Society & Residual Risk Reduction Initiative Publish Consensus Statement on New Treatment for Residual Cardiovascular Risk

MILAN and BASEL, Switzerland, Sept. 3, 2019 /PRNewswire/ -- A new highly selective treatment, a peroxisome proliferator-activated receptor alpha modulator (SPPARM-alpha) agonist, may help to address the gap in managing the residual risk of heart attacks and strokes in high-risk patients, accordin...

2019-09-03 07:44 3339

Syntellix Asia and Chunli Agree Far-reaching Co-operation to Introduce and Market Innovative "Quantum Leap in Implantology" MAGNEZIX® Medtech Devices in China

- Milestone contract signed between leading Chinese orthopaedic medtech supplier andSingapore based Asian subsidiary and hub of German world-market and technology leader in the area of bioabsorbable metallic implants for use in orthopaedic and trauma surgery - Contract volume of more than 100 mi...

2019-08-30 22:28 2675

DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds

NEW YORK, Aug. 30, 2019 /PRNewswire/ -- DarwinHealth today announced a multi-year scientific research collaboration with Celgene Corporation ("Celgene") to use quantitative systems biology-based algorithms, technologies that also underpin NY State CLIA-approved diagnostic tests in oncology, and ...

2019-08-30 01:59 3284

Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India

WETTEREN, Belgium, Aug. 29, 2019 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam,In...

2019-08-29 20:04 2785

Esco Ventures Announces the Launch of Carmine Therapeutics, a Company Pioneering Red Blood Cell (RBC)-Derived Extracellular Vesicle (EV)-Based Gene Therapies

SINGAPORE, Aug. 29, 2019 /PRNewswire/ -- Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of ProfessorsMinh Le and Jiahai Shi at the CityUniversity of Hong Kong. Carmine Therape...

2019-08-29 11:00 2220

Innovent Reports Interim Results for Fiscal Year 2019

SUZHOU, China, Aug. 29, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced its interim financial results for the six months endedJune 30, 2019. HIGHLIGHTS AND OTH...

2019-08-29 08:39 3460

Ascletis Received IND Approval for its NASH Drug

HANGZHOU, China and SHAOXING, China, Aug. 28, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that toget...

2019-08-28 08:00 4075

LBB Specialties Announces Strategic Partnership With MEGGLE On US Distribution Of Excipient Products

NORWALK, Connecticut, Aug. 28, 2019 /PRNewswire/ -- LBB Specialties announced that effectiveAugust 1, 2019, LBB has entered into a strategic partnership with MEGGLE Excipients & Technology to distribute MEGGLE's excipient products to companies in the American pharmaceutical and nutraceutical indu...

2019-08-28 06:00 2050

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020

1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million )                                   Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...

2019-08-28 04:16 8407

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020

1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million )                                   Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...

2019-08-28 04:16 9185

Origin Agritech Entered Collaboration Agreement with Biotechnology Research Institute of Chinese Academy of Agriculture Sciences to Speed up Commercialization of GM Traits in China

BEIJING, Aug. 27, 2019 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today announced that the Company has entered into a collaboration agreement with Biotechnology Research Institute (BRI) of Chinese Academ...

2019-08-27 20:00 4434

DiscGenics Receives FDA Fast Track Designation for Cell Therapy for Disc Degeneration

SALT LAKE CITY, Aug. 27, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that the U.S. Food and Drug ...

2019-08-27 07:00 2202

Atonarp Inc. Announces $33 Million Series C Funding Round Completion

- Financing round brings five new investors to Atonarp, including Japan Post Investment Corporation and SBI Investment Co., Ltd.  - Series C was oversubscribed as investor demand was driven by the company's accelerating development progress of disruptive healthcare diagnostics platform. - Fundin...

2019-08-26 07:00 2876